Cargando…
LHX3 is an early stage and radiosensitivity prognostic biomarker in lung adenocarcinoma
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. We previously identified LHX3 as a new preferentially expressed gene in NSCLC. In the present study, we sought to determine its expression, the clinical relevance and the functional roles in NSCLC. LHX3 expression is sharply...
Autores principales: | Lin, Xin, Li, Yan, Wang, Jin, Han, Fei, Lu, Shuang, Wang, Yu, Luo, Wenjian, Zhang, Mingqian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549242/ https://www.ncbi.nlm.nih.gov/pubmed/28731174 http://dx.doi.org/10.3892/or.2017.5833 |
Ejemplares similares
-
LHX6, An Independent Prognostic Factor, Inhibits Lung Adenocarcinoma Progression through Transcriptional Silencing of β-catenin
por: Yang, Juntang, et al.
Publicado: (2017) -
A Novel Prognostic Model of Early-Stage Lung Adenocarcinoma Integrating Methylation and Immune Biomarkers
por: Ren, Jin, et al.
Publicado: (2021) -
A prognostic predictor panel with DNA methylation biomarkers for early-stage lung adenocarcinoma in Asian and Caucasian populations
por: Kuo, I-Ying, et al.
Publicado: (2016) -
Trans-omics biomarker model improves prognostic prediction accuracy for early-stage lung adenocarcinoma
por: Dong, Xuesi, et al.
Publicado: (2019) -
CXCL9 as a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients
por: Zhang, Yanwei, et al.
Publicado: (2020)